Mark Levick, MD PhD and Andrew Roberts, MSc MBA are seasoned pharmaceutical professionals with proven track records in drug development from molecule to market: as drug developers, global team leaders and C-suite executives. They have experience in both Big Pharma and Small Biotech in the US and Europe. They combine scientific training, regulatory insight and commercial leadership with complementary expertise in executive coaching and executive mentoring. Mark brings expertise in executive coaching and leadership development, while Andrew contributes extensive experience in mentoring executives and leadership mentoring. Together, they help organisations navigate complex scientific, organisational and strategic challenges. Mark and Andrew work with a network of trusted and experienced colleagues to deliver Thaxton Philip Consulting services to clients worldwide.
Mark Levick, MD PhD
Partner
Mark Levick is a pharmaceutical physician, former UK/EU medicines regulator, former CEO of a NASDAQ-listed biopharmaceutical company and an independent board director. He has more than 25 years of international leadership experience across medicines regulation, global R&D and complex biologics.
Mark advises biotechnology companies, investors, boards and executive teams on drug development strategy, scientific due diligence, portfolio decisions and regulatory strategy. His expertise spans translational medicine, clinical development and complex biopharmaceuticals, including monoclonal antibodies, engineered proteins, biosimilars and cell and gene therapies.
His experience has been built in leadership roles at GlaxoSmithKline, Novartis, Sandoz and Alvotech in the UK, USA and Switzerland. As CEO of Alvotech, he led the company’s first product approval and launch, first-time EU GMP accreditation, pipeline expansion and NASDAQ listing. Across his career, he has contributed to 13 marketing approvals, including five first-in-class medicines.
Before moving into industry, Mark practised medicine in university hospitals in Australia and the UK. He holds a medical degree from the University of Newcastle, Australia, a PhD in vaccine development and a Diploma in Coaching from the University of Cambridge. He is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FFPM) and the Royal College of Pathologists of Australasia (FRCPA).
Mark is a qualified executive coach and teaches coaching psychology and coaching practice at the University of Cambridge. Executive coaching services are available through Mark's coaching practice at www.marklevick.com.
Andrew Roberts, MSc MBA
Partner
Andrew Roberts is a former pharmaceutical industry executive having served in C-suite biotech and senior pharmaceutical company roles. Andrew's experience spans many areas of the industry, including early research and translational medicine, clinical development, device development, and portfolio and board-level strategy for companies with both small molecule and biologic assets.
Andrew specializes in the intersection of R&D, Commercial, Manufacturing, Finance, Legal and Strategy and how to optimize activities to support long-term success. He also has extensive experience in organizational transformation and building, including preparing organizations for public listing. Andrew provides scientific advice, due diligence, organizational structure and governance, M&A and board advisory services for biotech start-ups, venture capital firms, portfolio companies, pharmaceutical SMEs, and firms that support investments in such organizations.
Andrew's experience has been built in organizations based in the US and Europe, including Novartis, Biogen Idec and Alvotech, and he has extensive experience working in Asia and South America as well. He has supported global marketing approval for over 20 assets, including small molecules, novel biologics and biosimilars. His passion is optimizing science and business, using his degrees in Biology from Louisiana State University and an Executive MBA from INSEAD in Paris.
Andrew is an experienced mentor to CEOs, founders and senior leadership teams, supporting executives through organisational growth, strategic decision-making and business transformation. To enquire about Andrew's executive mentoring, please use the contact form.
Our Mission
Purpose led service, for inspired outcomes
Thaxton Philip Consulting is passionate about creating a unique life sciences consulting offering that brings together the science of drug development with the science of teams. The outcome is inspired and purpose-led R&D teams that transform molecules into life-changing drugs through great teamwork.